Home
Categories
EXPLORE
Society & Culture
History
True Crime
Technology
News
Business
Comedy
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/89/55/21/89552172-8fb7-4f33-7fde-c151dbde48b0/mza_17670698278821398717.png/600x600bb.jpg
FDA Drug Safety Podcasts
U.S. Food and Drug Administration, Center for Drug Evaluation and Research
60 episodes
9 months ago
FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts
Show more...
Medicine
Government,
Health & Fitness,
Science,
Life Sciences
RSS
All content for FDA Drug Safety Podcasts is the property of U.S. Food and Drug Administration, Center for Drug Evaluation and Research and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts
Show more...
Medicine
Government,
Health & Fitness,
Science,
Life Sciences
https://www.fda.gov/files/DrugSafetyPodcast-iTunesAlbumGraphic_3000x3000-min.png
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
FDA Drug Safety Podcasts
3 minutes 30 seconds
1 year ago
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
FDA Drug Safety Podcasts
FDA Drug Safety Podcasts, produced by FDA's Center for Drug Evaluation and Research, provide emerging safety information about drugs in conjunction with the release of Drug Safety Communications. For more information, please visit: www.fda.gov/drugsafetypodcasts